**Question:** Increase in number of RBC is seen in

A. Dehydration
B. Anemia
C. Polycythemia
D. Hypoxia

**Correct Answer:** C. Polycythemia

**Core Concept:**
Understanding the regulation of red blood cell (RBC) production is crucial in understanding the correct answer. The human body maintains a stable RBC count through a complex interplay of factors including oxygen-binding affinity, hematocrit, and erythropoietin (EPO) production. Erythropoietin is a hormone produced primarily in the kidneys in response to hypoxia (option D) and low oxygen saturation in tissues. It stimulates RBC production in the bone marrow.

**Why the Correct Answer is Right:**
Polycythemia, also known as erythrocytosis, is a condition characterized by an increase in RBC count. This increase can be due to increased production or reduced destruction of RBCs. While dehydration (option A) and hypoxia (option D) can lead to increased EPO production and subsequently increased RBC counts, the primary cause in polycythemia is the increased production of RBCs in the bone marrow, without a compensatory increase in hematocrit or a decrease in EPO levels.

**Why Each Wrong Option is Incorrect:**

A. Dehydration: While dehydration can cause a decrease in blood volume, it does not directly lead to an increase in RBC production. The body responds to dehydration by increasing plasma volume and plasma proteins, not RBC count.

B. Anemia: Anemia is characterized by a decrease in RBC count, not an increase. In contrast to polycythemia, anemia results from decreased RBC production or increased RBC destruction.

D. Hypoxia: Hypoxia can lead to increased EPO production, resulting in increased RBC count. However, it is not the primary cause of polycythemia, as the main cause is increased RBC production without a compensatory increase in hematocrit or decrease in EPO levels.

**Clinical Pearl:**
Polycythemia (option C) is a clinical condition characterized by an increase in RBC count due to increased production in the bone marrow without an increase in hematocrit or decrease in EPO levels. This can occur from various causes, such as chronic kidney disease, high altitude, or the presence of erythropoietic agents (e.g., erythropoietic drugs like EPO). Polycythemia can lead to complications like blood clot formation, stroke, and myocardial infarction due to increased blood viscosity and reduced oxygen-carrying capacity. A thorough understanding of this concept is essential for clinical diagnosis and management of patients with polycythemia-related complications.